News Breaks |
|
|
| January 25, 2013 |
| 10:07 EDT |  | CHMT, SRPT, RHT, FOR, WPRT, OMCL, PKOH, BRO, SKS, EBAY, STRZA, MMC, BXP, AON, ACN, BIOS, AMZN, BMR, ACT | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Accenture (ACN) initiated with an Overweight at Evercore... Actavis (ACT) initiated with an Overweight at Morgan Stanley... Amazon.com (AMZN) initiated with a Buy at ISI Group... Aon Corp. (AON) initiated with a Market Perform at Wells Fargo... BioMed Realty (BMR) initiated with a Neutral at Goldman... BioScrip (BIOS) initiated with a Buy at SunTrust... Boston Properties (BXP) initiated with an Overweight at Evercore... Brown & Brown (BRO) initiated with a Market Perform at Wells Fargo... Forestar Group (FOR) initiated with a Buy at DA Davidson... Marsh & McLennan (MMC) initiated with an Outperform at Wells Fargo... Park-Ohio (PKOH) initiated with an Outperform at Imperial Capital... Red Hat (RHT) initiated with an Outperform at Northland Securities... Starz (STRZA) initiated with a Sell at Stifel Nicolaus... Starz (STRZA) initiated with an Underweight at Evercore... Omnicell (OMCL) initiated with a Buy at Benchmark Co... Sarepta (SRPT) initiated with an Outperform at Cowen... eBay (EBAY) initiated with a Positive at Susquehanna... Westport Innovations (WPRT) initiated with a Market Perform at Raymond James... Chemtura (CHMT) initiated with a Buy at Sidoti... Saks (SKS) initiated with a Buy at Maxim. |
|
|
News For ACN;ACT;AMZN;AON;BMR;BIOS;BXP;BRO;FOR;MMC;PKOH;RHT;STRZA;OMCL;SRPT;EBAY;WPRT;CHMT;SKS From The Last 14 Days Check below for free stories on ACN;ACT;AMZN;AON;BMR;BIOS;BXP;BRO;FOR;MMC;PKOH;RHT;STRZA;OMCL;SRPT;EBAY;WPRT;CHMT;SKS the last two weeks. |
|
|
| May 14, 2013 |
| 13:36 EDT |  | ACT | Actavis discussing over $5B bid for Warner Chilcott, Bloomberg reports
Bloomberg cites a source. |
|
| 13:22 EDT | | ACT | Actavis turned down $15B takeover bid from Mylan, Bloomberg reports
 Subscribe for More Information |
|
| 07:54 EDT |  | AMZN | Amazon's employees in Germany to strike for pay, benefits, Reuters reports
Subscribe for More Information |
|
| 07:18 EDT |  | ACT | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. |
|
| 07:05 EDT | | AMZN | Netflix continues to lead web usage in North America, AllThingsD reports
Subscribe for More Information |
|
| 06:31 EDT | | ACN | Accenture selected by Reale Mutua Assicurazioni Group subsidiary
Subscribe for More Information |
|
| 06:17 EDT | | ACN | Accenture awarded contract management consulting contract by Tullow Oil
Subscribe for More Information |
|
| May 13, 2013 |
| 15:22 EDT | | AMZN | Amazon confirms purchase of Samsung screen technology, The Digital Reader says
Subscribe for More Information |
|
| 12:56 EDT | | WPRT | Westport Innovations mentioned cautiously by Seeking Alpha contributor
Subscribe for More Information |
|
| 12:14 EDT |  | ACT | Actavis price target raised to $140 from $125 at Buckingham
Subscribe for More Information |
| |
| 10:09 EDT |  | BMR | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:04 EDT | | ACT | Actavis NDA for progestin-only patch accepted for filing by FDA
Subscribe for More Information |
|
| 09:00 EDT | | ACT | Warner Chilcott price target raised to $21 from $18 at Susquehanna
Susquehanna raised its price target on Warner Chilcott (WCRX) following its confirmation it is in discussions with Actavis (ACT) about a business combination. The firm believes the possible combination is compelling and worth exploring. Shares are Positive rated. |
|
| 08:19 EDT | | RHT | Red Hat becoming innovator, says Wells Fargo
Subscribe for More Information |
|
| 07:49 EDT | | ACT | FDA decision on Opana a modest positive for Impax, says Leerink
Leerink views the FDA's denial of Endo's (ENDP) Citizen Petition as a modest positive for Impax (IPXL), which it notes is the sole holder of 180 day exclusivity on generic Opana. However, Leerink says upside for Impax will be limited as Actavis (ACT), Sandoz, and Teva (TEVA) have settlements to enter the market starting in June 2013 when Impax's 180-day generic exclusivity expires. |
|
| 07:42 EDT | | BMR | BioMed Realty upgraded to Buy from Hold at Stifel
Subscribe for More Information |
|
| 07:14 EDT | | EBAY | eBay revenue, EPS likely to accelerate in 2H13, says Bernstein
Bernstein expects eBay's revenue and EPS growth to accelerate in 2H13, as implied by the company's guidance. The firm expects the company to benefit from continued user growth in Marketplaces and PayPal. The firm keeps an Outperform rating on the shares. |
|
|
|
|
|
